Results 11 to 20 of about 129,082 (304)
Hormesis and Endothelial Progenitor Cells [PDF]
Hormetic-biphasic dose response relationships are reported herein for human endothelial progenitor cells involving estradiol, nicotine, the anti-diabetic agent pioglitazone, resveratrol, and progesterone.
Edward J. Calabrese PhD
doaj +3 more sources
Cancer, a proliferative disease hallmarked by abnormal cell growth and spread, is largely dependent on tumor neoangiogenesis, with evidence of vascular endothelial dysfunction.
P.K.Y. Goon +4 more
doaj +3 more sources
Endothelial cells and endothelial progenitor cells in the pathogenesis of systemic sclerosis
Systemic sclerosis (SSc) is a connective tissue disease characterized by excessive fibrosis, microvasculopathy, and autoimmunity. Endothelial cell (EC) injury and subsequent endothelial cell dysfunction is believed to be an initial event that eventually leads to a vicious pathogenic cycle.
Yuko Ota, Masataka Kuwana
doaj +3 more sources
Endothelial Progenitor Cells [PDF]
Vascular endothelial cells form a lining — one cell thick — for all the blood vessels in the body, providing a critical interface between the vessel itself and blood-borne elements.
Mihail, Hristov +2 more
+6 more sources
Endothelial Progenitor Cells [PDF]
Endothelial progenitor cells are a circulating, bone marrow–derived cell population that appears to participate in both vasculogenesis and vascular homeostasis. Questions persist regarding their functional characteristics, as well as the precise panel of cell surface markers that uniquely define this newly described progenitor cell population.
Aarif Y, Khakoo, Toren, Finkel
openaire +4 more sources
Endothelial progenitor cells in atherosclerosis [PDF]
Endothelial progenitor cells (EPCs) are involved in the maintenance of endothelial homoeostasis and in the process of new vessel formation. Experimental and clinical studies have shown that atherosclerosis is associated with reduced numbers and dysfunction of EPCs; and that medications alone are able to partially reverse the impairment of EPCs in ...
Fuyong, Du +8 more
openaire +2 more sources
Endothelial progenitor cells in pregnancy [PDF]
Abstract The discovery of endothelial progenitor cells has generated considerable interest in the field of vascular biology. These cells arise from a population of circulating mononuclear cells and have the capacity to form new blood vessels and contribute to vascular repair. Circulating endothelial progenitor cell numbers are reduced
Amy O, Robb +3 more
openaire +2 more sources
Circulating endothelial progenitor cells [PDF]
Angiogenesis research investigates the formation of new blood vessels in wound healing, tumour growth and embryonic development. Circulating, bone marrow-derived endothelial progenitor cells (EPCs) were first described 8 years ago, yet the exact nature of these endothelial precursor cells remains unclear.
Garmy-Susini, B, Varner, J A
openaire +2 more sources
Endothelial Progenitor Cells in Prehypertension
Blood pressure within prehypertensive levels confers higher cardiovascular risk. As prehypertension is also an intermediate stage for full hypertension, a precocious intervention with lifestyle changes or drugs is therefore appealing. Endothelial injury and dysfunction are thought to contribute to cardiovascular risk in prehypertension.
DI STEFANO, ROSSELLA +4 more
openaire +4 more sources
Mobilizing Endothelial Progenitor Cells [PDF]
Mobilization of endogenous endothelial progenitor cells (EPCs) from the bone marrow may be an alternative way to increase neovascularization and may be used as therapeutic option for the treatment of ischemic cardiovascular diseases. In this review, we discuss the EPC mobilizing effects of pro-inflammatory cytokines such as granolocyte monocyte colony ...
Alexandra, Aicher +2 more
openaire +2 more sources

